- Home
- XRX vs SAGE Comparison
XRX vs SAGE Comparison
Compare XRX & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRX
- SAGE
- Stock Information
- Founded
- XRX 1906
- SAGE 2010
- Country
- XRX United States
- SAGE United States
- Employees
- XRX N/A
- SAGE N/A
- Industry
- XRX Computer peripheral equipment
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- XRX Technology
- SAGE Health Care
- Exchange
- XRX Nasdaq
- SAGE Nasdaq
- Market Cap
- XRX 674.2M
- SAGE 571.1M
- IPO Year
- XRX N/A
- SAGE 2014
- Fundamental
- Price
- XRX $5.12
- SAGE $9.27
- Analyst Decision
- XRX Sell
- SAGE Hold
- Analyst Count
- XRX 3
- SAGE 18
- Target Price
- XRX $9.00
- SAGE $9.89
- AVG Volume (30 Days)
- XRX 3.4M
- SAGE 3.2M
- Earning Date
- XRX 07-24-2025
- SAGE 07-30-2025
- Dividend Yield
- XRX 9.81%
- SAGE N/A
- EPS Growth
- XRX N/A
- SAGE N/A
- EPS
- XRX N/A
- SAGE N/A
- Revenue
- XRX $6,176,000,000.00
- SAGE $47,404,000.00
- Revenue This Year
- XRX $0.80
- SAGE $102.21
- Revenue Next Year
- XRX $14.78
- SAGE $43.01
- P/E Ratio
- XRX N/A
- SAGE N/A
- Revenue Growth
- XRX N/A
- SAGE N/A
- 52 Week Low
- XRX $3.45
- SAGE $4.62
- 52 Week High
- XRX $12.29
- SAGE $13.47
- Technical
- Relative Strength Index (RSI)
- XRX 43.85
- SAGE 73.46
- Support Level
- XRX $5.14
- SAGE $9.10
- Resistance Level
- XRX $5.90
- SAGE $9.22
- Average True Range (ATR)
- XRX 0.27
- SAGE 0.12
- MACD
- XRX -0.05
- SAGE -0.05
- Stochastic Oscillator
- XRX 11.29
- SAGE 71.88
About XRX Xerox Holdings Corporation
Xerox Holdings Corp is an original equipment manufacturing and software company. Xerox operates in one segment--design, development, and sale of printing technology and related solutions--while deriving 60% of its revenue from the U.S. and 40% from international markets. The company is an OEM of multifunction printers, or MFPs (printers that can print, copy, and scan), focusing on large enterprise markets. Apart from equipment, the company provides post-sales services like managed print services help to bring smart servicing and efficiencies to how employers use their print/copy equipment. Xerox is attempting to enter new markets like digital print packaging solutions and printed electronics.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.